Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD

This study is not currently open for recruitment.

Study Sponsor: Chugai Pharmaceuticals

Clinical Trials.Gov Identifier: NCT02073279

Essential Grid Modal
×